Related Experiment Videos
Dose variation at bone/titanium interfaces using titanium hollow screw osseointegrating reconstruction plates
A S Allal1, M Richter, M Russo
1Division of Radiation Oncology, University Hospital, Geneva, Switzerland.
International Journal of Radiation Oncology, Biology, Physics
|January 9, 1998
Summary
Dose variations at bone/titanium interfaces around titanium hollow-screw osseointegrating reconstruction plate (THORP) screws were marginally significant. These findings suggest that overdosage at the interface is unlikely to cause prosthetic osseointegration failures in head and neck cancer patients.
Area of Science:
- Biomaterials Science
- Medical Physics
- Oral and Maxillofacial Surgery
Background:
- Mandibular reconstruction often involves titanium implants.
- Postoperative radiotherapy is sometimes used in head and neck cancer treatment.
- Potential interactions between radiotherapy and bone-implant interfaces require investigation.
Purpose of the Study:
- To quantify radiation dose variations at bone/titanium interfaces.
- To evaluate these variations in an experimental model simulating radiotherapy after mandibular reconstruction.
- To assess the impact of the titanium hollow-screw osseointegrating reconstruction plate (THORP) system.
Main Methods:
- An experimental model using bovine femoral bone and a THORP system was developed.
- Thermoluminescent dosimeters (TLDs) measured doses at various distances from the screw axis.
- 60Co and 6-MV photon beams were used with perpendicular and axial incidences relative to the screw axis.
Main Results:
- Perpendicular incidence: Maximum dose enhancement of 5-6% and reduction of 6-10% for 6-MV and 60Co beams, respectively.
- Axial incidence: Maximum dose enhancement of 5-7% when beams hit the plate surface, and 2-3% for opposite surface incidence.
- All measured dose variations were close to the TLD method's uncertainty limits (+/- 5%).
Conclusions:
- Dose variations at bone/titanium interfaces around THORP screws are marginally significant.
- Dose variations were smaller for axial incidences compared to perpendicular incidences.
- Results suggest that overdosage at the bone/titanium interface is unlikely to be the cause of prosthetic osseointegration failures.